- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.07. | Bavarian Nordic confirms buyout talks with private equity firms amid new chikungunya threats | ||
| 24.07. | Tariffs, pricing policy changes bring industry to a 'pivotal moment': Deloitte survey | ||
| 24.07. | Viatris beats Novo in semaglutide patent feud, clearing hurdle for potential Wegovy generic | ||
| 24.07. | After M&A plays, CDMO Sanner cements North American presence with 1st US plant | ||
| 24.07. | Leo roars to key FDA nod for Anzupgo to treat chronic hand eczema | ||
| 23.07. | RFK Jr. rubber-stamps ACIP recommendation to remove thimerosal from all vaccines in US | ||
| 23.07. | FDA delays Blenrep decision, putting GSK's multiple myeloma comeback dreams on ice | ||
| 23.07. | 10 years of Tagrisso: AstraZeneca unveils first TV ad for lung cancer treatment | ||
| 23.07. | Roche halts Elevidys distribution in some countries, following Sarepta's lead in US | ||
| 23.07. | Genentech eliminates 87 jobs in another round of South San Francisco layoffs | ||
| 23.07. | CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling | ||
| 23.07. | Kyowa, Amgen and Sanofi back push to change websites that miss the mark on women's health | ||
| 23.07. | Orient Pharma, AvKARE recall nearly 80K bottles of cholesterol drug over impurity concerns | ||
| 23.07. | FDA opens national priority fast track, offering 2-month reviews to onshoring and affordability projects | ||
| 22.07. | 'We want to be different than pharma': Evofem CEO on the TikTok that tripled interest in Phexxi birth control | ||
| 22.07. | AbbVie wins $56M royalty award from Revance in Botox patent infringement case | ||
| 22.07. | Avalyn raises $100M to advance inhaled versions of approved lung disease meds | ||
| 22.07. | UK marketing watchdog slams Theramex for 'wholly unacceptable' compliance failings | ||
| 22.07. | Sarepta, bowing to FDA pressure, pauses shipments of Duchenne gene therapy Elevidys | ||
| 22.07. | GSK telegraphs 150 layoffs amid plan to transfer vaccine manufacturing from Massachusetts site | ||
| 21.07. | AstraZeneca, facing lung cancer challenge from J&J, touts life extension benefit for Tagrisso combo | ||
| 21.07. | Lundbeck, Otsuka's PTSD bid for Rexulti dealt a setback at FDA advisory committee | ||
| 21.07. | Biogen ups its ante in North Carolina, pledging $2B manufacturing investment | ||
| 21.07. | FDA names next CDER director in biotech vet George Tidmarsh | ||
| 21.07. | Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .